Gray zone, actively moving (as of late July 2026): BPC-157, TB-500, CJC-1295, and others came off the restricted list in April 2026
What sets Ipamorelin apart is its selectivity, as it does not appear to influence the release of other hormones from the pituitary gland, such as prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), or Adrenocorticotropic hormone (ACTH)
In muscle-focused research discussions, this combination is commonly associated with: Muscle protein synthesis signaling models Recovery pathway analysis Fat metabolism research Cellular regeneration mechanisms Because of this synergistic interaction, CJC-1295 + Ipamorelin is often considered one of the most popular peptide stacks in the muscle growth research category
Natural GLP-1 Activation: As the gut microbiome is nourished through consistent daily use, the manufacturer describes a downstream effect on the body's natural GLP-1 production